Scholars Central

ArticlePublished 3 Feb 2023

Lung cancer increased risk with long term use of angiotensin converting enzyme inhibitors a systematic review

Authors: Omer Ibrahim A Omer, Abdelhafiz Mohammed Abdalla

Systematic Reviews in Pharmacy

Volume 14 · Issue 2 · Pages 82–90

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The aim of this study is to investigate the risk of lung cancer linked with the use of Angiotensin- Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARB) and Overall Survival for lung cancer. Methods: By using specific terminologies related to cancer and the inhibitors of ACEIs/ARBs, we searched on several research databases for studies that used to investigate the lung cancer risk associated with patients uses of ACEIs/ARBs. Results: Thirty two studies met the inclusion criteria. In two investigations, individuals with advanced pancreatic cancer (HR=0.52, %CI 0.29-0.88) and non-small cell lung cancer (HR=0.56, %CI 0.33-0.95) had a substantial improvement in Overall Survival (OS). Long-term usage of ACEIs/ARBs was linked to an elevated risk of lung cancer in six studies. While the other investigations concluded the use of ACEIs/ARBs was not significantly associated with increased risk of overall incident of lung cancer. Conclusion: There is some evidence to suggest that ACEI or ARB use may be associated with lung cancer. Larger and more robust studies are required to explore this relationship further.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Systematic Reviews in Pharmacy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Omer Ibrahim A Omer”
  • BylineArticles whose byline prints “Abdelhafiz Mohammed Abdalla”